Overview
Status
Active
Registry date
2018-10-29
Share capital
5,000.00 PLN
Registered address
Warszawa, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Nafeh Attar – President of the Management Board
Mohamed Salah Hegazyage 42 – Management Board Member
Manner of representation
Each member of the management board is independently authorised to make declarations concerning the company’s proprietary and non-proprietary rights and obligations and to represent the company in and out of court.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Nafeh Attar | 100 | $1,350.62 | 100% |
Beneficial owners
No beneficial owners recorded for the company DAR Alattar.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-04 | Address change (Ul. Tytoniowa 20/A107, 04-228, Warszawa → Warszawa) | |
| 2023-09-12 | Name change (Innopharma Europe → Dar Alattar) | |
| 2018-10-29 | Entered in the register |
FAQ
Last updated: 2026-10-07